SurgeonsLab Company Profile

Background

Mission and Vision

SurgeonsLab is dedicated to enhancing patient safety and surgical precision through advanced simulation technologies. By developing patient-specific training models, the company aims to improve clinical outcomes and redefine surgical education and planning.

Primary Area of Focus and Industry Significance

Specializing in the creation of realistic, patient-specific models for microsurgical procedures and endovascular interventions, SurgeonsLab addresses the critical need for precise surgical training and device validation. Their innovative approach offers a significant advancement over traditional training methods, contributing to the evolution of medical education and patient care.

Key Strategic Focus

Core Objectives

Enhancing Surgical Training: Developing high-fidelity simulators that replicate real-life surgical scenarios to improve surgeon proficiency.

Validating Medical Devices: Providing platforms for testing and refining medical devices in realistic settings before clinical application.

Specific Areas of Specialization

Microsurgery Training: Focusing on intricate surgical procedures requiring high precision.

Endovascular Interventions: Simulating catheter-based procedures to ensure safety and efficacy.

Key Technologies Utilized

3D Printing: Employing additive manufacturing to create detailed anatomical models.

Simulation Software: Integrating interactive interfaces with step-by-step guides for comprehensive training.

Primary Markets Targeted

Medical Institutions: Hospitals and surgical centers seeking advanced training solutions.

Medical Device Manufacturers: Companies requiring realistic testing environments for product development.

Financials and Funding

Funding History

SurgeonsLab has secured funding through grants, notably receiving CHF 150,000 from the Ypsomed Innovation Fund in January 2021.

Total Funds Raised

The company has raised a total of CHF 160,000 through grant funding.

Notable Investors

Ypsomed Innovation Fund: Provided the primary grant funding to support SurgeonsLab's initiatives.

Intended Utilization of Capital

The funds have been allocated to scale up the production of 4D simulators and to facilitate early market entry, particularly in international markets.

Pipeline Development

Key Pipeline Candidates

SurgTrain™: A comprehensive platform dedicated to providing advanced training and education for medical professionals, particularly in surgical simulation.

CathTrain™: An autonomous endovascular simulator for interventional radiologists, offering realistic training in patient-specific scenarios.

Stages of Development

Both SurgTrain™ and CathTrain™ are in the advanced stages of development, with prototypes validated by medical professionals and plans for broader deployment underway.

Target Conditions

SurgTrain™: Aims to enhance training for various surgical procedures, focusing on microsurgery and endovascular interventions.

CathTrain™: Targets the training needs of interventional radiologists, particularly in complex catheter-based procedures.

Anticipated Milestones

Product Launch: Scheduled for July 2021 at SITEM Insel, Bern, including training sessions for specialists and expert neurosurgeons.

Market Expansion: Plans to enter international markets, with pre-orders from institutions like Inselspital Bern and Harvard Medical School.

Technological Platform and Innovation

Proprietary Technologies

Patient-Specific Models: Utilizing medical image data to create detailed 3D simulations of patient anatomy.

4D Simulation Technology: Incorporating temporal dynamics to replicate real-time surgical scenarios.

Significant Scientific Methods

Additive Manufacturing: Employing 3D printing techniques to produce accurate anatomical models.

Simulation Software Integration: Combining interactive software interfaces with step-by-step simulation guides for comprehensive training.

Leadership Team

Dr. Fredrick Johnson Joseph

Position: Founder and CEO

Background: Pursuing a PhD at ARTORG Center for Biomedical Engineering Research in Bern.

Contributions: Led the development of SurgeonsLab's innovative simulation technologies.

Dr. David Bervini

Position: Co-Founder and Chief Medical Officer

Background: Staff neurosurgeon at Inselspital in Bern.

Contributions: Provided medical expertise to ensure the clinical relevance of SurgeonsLab's products.

Advisory Board

Prof. Dr. Andreas Raabe: Neurosurgeon, Switzerland - European Markets

Prof. Dr. Michael K. Morgan: Veteran Surgeon, Asia Pacific Markets

Dr. Saleem Abdulrauf: Neurosurgeon, American Markets

Dr. Christian Schaub: Business Angel, Successful Exits

Dr. Armin W. Mader: Business Coach, Successful Exits

Stéphane Fallot: Experienced Fundraiser, Successful Exits

Competitor Profile

Market Insights and Dynamics

The surgical simulation market is experiencing rapid growth, driven by the increasing demand for minimally invasive procedures and the need for advanced training solutions. Key players in this market include Medtronic, Stryker, and Johnson & Johnson, who are investing heavily in simulation technologies to enhance surgical precision and patient outcomes.

Competitor Analysis

Medtronic: Offers a range of surgical simulation products, including the Hugo Robotic-Assisted Surgery system, emphasizing advanced technologies in respiratory, gastrointestinal, and renal care.

Stryker: Provides a diverse portfolio covering surgical equipment, safety technologies, and communication systems, with a focus on enhancing patient and caregiver safety.

Johnson & Johnson: Develops surgical simulation tools like the PROXIMATE Plus MD Skin Stapler and HARMONIC 1100 Shears, focusing on reliable performance and advanced stapling solutions.

Strategic Collaborations and Partnerships

SurgeonsLab has established collaborations with leading medical institutions, including Inselspital Bern and Harvard Medical School, to validate and refine their simulation technologies.

Operational Insights

SurgeonsLab differentiates itself by offering patient-specific, high-fidelity simulation models that closely replicate real-life surgical scenarios, providing a more effective training environment compared to traditional methods.

Strategic Opportunities and Future Directions

The company plans to expand its product offerings to include additional surgical specialties and to enter new international markets, leveraging its innovative simulation technologies to enhance surgical training and patient safety globally.